Search results

Jump to navigation Jump to search
  • ...ntial therapeutic applications. The compound is part of a broader class of drugs known as [[antiviral agents]], which are designed to combat viral infection ...the compound, followed by a unique numerical identifier. The exact origins of the name are proprietary information and not publicly disclosed.
    2 KB (207 words) - 22:53, 4 February 2024
  • ...-dih-sin) A system in which doctors and other healthcare professionals (e. g.  ...ox medicine and western medicine {{dictionary-stub}} [[Category:Dictionary of medicine]]
    672 bytes (81 words) - 07:43, 12 January 2023
  • ...-dih-sin) A system in which doctors and other healthcare professionals (e. g.  ...al medicine and western medicine {{dictionary-stub}} [[Category:Dictionary of medicine]]
    644 bytes (75 words) - 01:28, 8 January 2023
  • ...-dih-sin) A system in which doctors and other healthcare professionals (e. g.  ...dicine and conventional medicine {{dictionary-stub}} [[Category:Dictionary of medicine]]
    660 bytes (79 words) - 19:57, 12 January 2023
  • ...-dih-sin) A system in which doctors and other healthcare professionals (e. g.  ...al medicine and western medicine {{dictionary-stub}} [[Category:Dictionary of medicine]]
    656 bytes (77 words) - 01:30, 8 January 2023
  • ...the neurotransmitter [[acetylcholine]]. The term is derived from the name of the chemical compound, acetylcholine, and the Greek word "ergon", meaning w The term "cholinergic" is derived from the name of the neurotransmitter, [[acetylcholine]], and the Greek word "ergon", meanin
    2 KB (301 words) - 14:34, 6 February 2024
  • '''FGI-103''' (pronounced: F-G-I-103) is a [[medical term]] used in the field of [[pharmacology]] and [[medicine]]. The term FGI-103 is an [[acronym]] that stands for '''F'''irst '''G'''eneration '''I'''nhibitor-103. The number 103 is a sequential number assi
    1 KB (150 words) - 23:13, 4 February 2024
  • ...] used in the treatment of [[type 2 diabetes]]. It belongs to the class of drugs known as [[Dipeptidyl peptidase-4 inhibitors]] or '''DPP-4 inhibitors'''. EGLU is pronounced as "e-g-l-u".
    1 KB (208 words) - 21:32, 3 February 2024
  • ...unt of money a health-insured patient pays for each healthcare service, e. g.  ...service. Also called co-payment {{dictionary-stub}} [[Category:Dictionary of medicine]]
    612 bytes (83 words) - 02:35, 11 January 2023
  • ...engines. It was formerly used as a general anesthetic, until non-flammable drugs were developed, such as [[halothane]]. It has a pungent smell. ..., and restrictions exist in countries because of its use in the production of [[methamphetamine]].
    2 KB (286 words) - 22:36, 8 February 2024
  • ...ients with certain types of cancer and neutropenia caused by certain types of chemotherapy and in patients with severe chronic neutropenia not caused by ...osphate dehydrogenase deficiency {{dictionary-stub}} [[Category:Dictionary of medicine]]
    1 KB (186 words) - 02:51, 8 January 2023
  • ...[pharmaceutical drug]] developed by [[Pfizer]] for the potential treatment of [[myocardial infarction]], also known as a heart attack. ...g company, Pfizer. The "CP" stands for Central Pharmaceuticals, a division of Pfizer. The number "532,903" is a sequential number assigned to the compoun
    1 KB (151 words) - 02:25, 6 February 2024
  • ...mone therapy and hormone therapy {{dictionary-stub}} [[Category:Dictionary of medicine]]
    895 bytes (126 words) - 19:38, 11 January 2023
  • The '''Histamine H3 receptor''' ('''H3R''') is a [[G-protein coupled receptor]] (GPCR) that belongs to the [[histamine receptor] ...c compound. The "H3 receptor" part of the name refers to the third subtype of histamine receptors discovered.
    2 KB (190 words) - 22:12, 14 February 2024
  • ...ne therapy and hormone treatment {{dictionary-stub}} [[Category:Dictionary of medicine]]
    898 bytes (126 words) - 19:05, 11 January 2023
  • ...ne therapy and hormone treatment {{dictionary-stub}} [[Category:Dictionary of medicine]]
    902 bytes (126 words) - 12:52, 11 January 2023
  • ...y developed for the treatment of [[colorectal cancer]]. It is a derivative of [[sulindac]], a non-steroidal anti-inflammatory drug (NSAID). ...common pharmaceutical prefix, often used to denote a derivative or variant of a parent compound.
    1 KB (205 words) - 16:47, 5 February 2024
  • ...amine''', is a [[psychedelic]] and [[hallucinogenic]] drug. It is a member of the [[tryptamine]] family. ...tamine", indicating the two isopropyl groups attached to the nitrogen atom of the tryptamine.
    2 KB (227 words) - 23:32, 3 February 2024
  • ...ibitors''', are a class of [[medication]]s used primarily in the treatment of [[type 2 diabetes]]. ...glucose in the kidney, and by inhibiting it, these drugs reduce the amount of glucose reabsorbed, leading to a reduction in blood glucose levels.
    2 KB (245 words) - 17:41, 9 February 2024
  • ...] and has been used in scientific research to help understand the function of the 5-HT2A receptor. ...cking the activity of this receptor, Volinanserin can modulate the effects of serotonin in the brain.
    2 KB (251 words) - 02:30, 7 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)